Answers are grounded in this paper and cite their sources.
Developmental toxicity testing requires human-relevant approaches that provide both predictive information and mechanistic insight. Here, we investigated the relative contributions of cytotoxicity and targeted transcriptomics to developmental toxicity assessment in a human induced pluripotent stem cell-based model of early neuroectodermal differentiation. A biologically anchored 190-gene transcript biomarker panel was derived from a previously published transcriptome dataset using complementary biomarker-selection strategies. An independent set of 18 developmental toxicants and non-toxicants was then evaluated based on concentration-dependent cytotoxicity normalized to maternal plasma C max values and biomarker expression. We found that cytotoxicity provided substantial discriminatory power in random forest-based classification of developmental toxicants and non-toxicants, yielding an AUC of 0.852, demonstrating robust discrimination for a complex and heterogeneous toxicological endpoint. In contrast, transcriptional responses were frequently detected at concentrations substantially below those causing cytotoxicity, but this increased sensitivity did not improve random forest classification of the two groups. Instead, targeted transcriptional profiling revealed compound-specific perturbation patterns that were not captured by cytotoxicity. Principal component analysis and Differentiation Pattern Clustering (DiPaC) distinguished impaired progression towards neuroectodermal identity from activation of divergent developmental transcriptional programs, exemplified by methoxyacetic acid and dimethadione, respectively. These findings demonstrate that cytotoxicity assessment normalized to physiological maternal plasma concentrations can provide substantial discriminatory information in an in vitro model of early embryonic development, while targeted transcriptional profiling provides complementary mechanistic insight into how developmental differentiation is perturbed. Distinguishing predictive from mechanistic value may therefore be important for the interpretation and integration of transcriptomic endpoints in developmental toxicity assessment.
No takes yet. Share an insight, caveat, or question.
Scholtz-Illigens et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: